TY - JOUR T1 - Hepatocellular carcinoma: Options for diagnosing and managing a deadly disease JF - Cleveland Clinic Journal of Medicine JO - Cleve Clin J Med SP - 645 LP - 653 DO - 10.3949/ccjm.80a.12163 VL - 80 IS - 10 AU - Arvind R. Murali AU - Carlos Romero-Marrero AU - Federico Aucejo AU - K.V. Narayanan Menon Y1 - 2013/10/01 UR - http://www.ccjm.org/content/80/10/645.abstract N2 - Hepatocellular carcinoma (HCC) is an important cause of death in patients with liver disease, and its incidence appears to be rising in the United States. Because early diagnosis improves the chances of survival, it is important to identify patients who would benefit from surveillance. Once HCC is suspected on surveillance, noninvasive diagnostic tests are available to make an accurate diagnosis. Treatment should be individualized, based on the characteristics of the tumor and the degree of liver dysfunction. ER -